Dr. Jaulang Hwang 黃昭蓮博士

Publications

1. Onda, M., Nagata, S., FitzGerald, D.J., Beers, R., Fisher, R.J., Vincent, J.J., Lee, B., Nakamura, M., Hwang, J., Kreitman, R.J., Hassan, R., and Pastan, I. (2006) Characterization of the B cell epitopes associated with a truncated form of pseudomonas exotoxin (PE38) used to make immunotoxins for the treatment of cancer patients. J. Immunol. 177, 8822-8834.
2. Yang M, Hsu CT, Ting CY, Liu LF, Hwang J.(2006) Assembly of a polymeric chain of SUMO1 on human topoisomerase I in vitro. J Biol Chem 281. 8264-8274.
3. Ting CY, Hsu CT, Hsu HT, Su JS, Chen TY, Tarn WY, Kuo YH, Whang-Peng J, Liu LF, and Hwang, J. (2003) Isodiospyrin as a novel human DNA topoisomerase I inhibitor. Biochem Pharmacol. 66, 1981-1991.
4. Xiao, H., Mao, Y., Deasi, SD., Zhou, N., Ting, C.-Y., Hwang, J., and Liu, L.F. (2003) The Topoisomerase IIβ Circular Clamp Arrests Transcription and Signals a 26S Proteasome Pathway. Proc. Natl. Acad. Sci. USA. 100, 3239-3244.
5. Hsu, C-T, Ting, C-Y and Hwang, J. (2003) Toxin in the development of vaccines. In: Chimeric Toxins: Mechanisms of Action and Therapeutic Application. pp.247-260. Academic Publishers. (book review).
6. Mao Y, Desai S, Ting CY, Hwang, J., and Liu, L.F. (2001) 26S Proteasome-mediated Degradation of Topoisomerase II Cleavable Complexes. J. Biol. Chem. 276, 40652-40658.
7. Hsu, C.-T., Ting, C.-Y., Ting, C.-J., Chen, T.-Y., Lin, C.-P., Whang-Peng, J., and Hwang, J. (2000) Vaccination against GnRH using toxin receptor binding domain-conjugated GnRH repeats. Cancer Research. 60, 3701-3705.
8. Chen, H.-J., Hwong, C.-L., Wang, C.-H., and Hwang, J. (2000) Degradation of DNA topoisomerase I by a novel trypsin-like serine protease in proliferating human T lymphocyte. J. Biol. Chem. 275, 13109-13117.